CeriBell Inc. (CBLL)
NASDAQ: CBLL
· Real-Time Price · USD
16.32
0.23 (1.43%)
At close: May 01, 2025, 3:25 PM
1.43% (1D)
| Bid | 16.22 |
| Market Cap | 585.37M |
| Revenue (ttm) | 65.44M |
| Net Income (ttm) | -40.45M |
| EPS (ttm) | -3.39 |
| PE Ratio (ttm) | -4.81 |
| Forward PE | -10.51 |
| Analyst | Buy |
| Ask | 16.46 |
| Volume | 166,411 |
| Avg. Volume (20D) | 270,916 |
| Open | 16.14 |
| Previous Close | 16.09 |
| Day's Range | 15.66 - 16.41 |
| 52-Week Range | 10.01 - 32.75 |
| Beta | 1.74 |
About CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its nam...
Industry Medical - Devices
Sector Healthcare
IPO Date n/a
Employees 281
Stock Exchange NASDAQ
Ticker Symbol CBLL
Website https://ceribell.com
Analyst Forecast
According to 6 analyst ratings, the average rating for CBLL stock is "Buy." The 12-month stock price forecast is $32, which is an increase of 96.08% from the latest price.
Stock Forecasts
